ClinicalTrials.govpublic full text
Acalabrutinib and Anti-CD19 CAR T-cell Therapy for the Treatment of B-cell Lymphoma
b-cell non-hodgkin lymphoma, diffuse large b-cell lymphoma, not otherwise specified, high grade b-cell lymphoma, primary mediastinal (thymic) large b-cell lymphoma, transformed follicular lymphoma to diffuse large b-cell lymphoma, grade 1 follicular lymphoma
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 474745
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.